Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma

Hereditary leiomyomatosis renal cell carcinoma (HLRCC)-associated renal tumors are aggressive and tend to metastasize early. There are currently no effective forms of therapy for patients with advanced HLRCC-associated kidney cancer. We have previously shown that HLRCC cells express a high level of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sourbier, Carole, Valera-Romero, Vladimir, Giubellino, Alessio, Yang, Youfeng, Sudarshan, Sunil, Neckers, Len, Linehan, W Marston
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2010
Teme:
Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055201/
https://ncbi.nlm.nih.gov/pubmed/20953139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.9.20.13458
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items